Selected "Top Doc 2012" by Northern Virginia Magazine: February 2012 Issue
Tue, 01/24/2012 - 12:54 — admin01/24/2012 - 17:52
Etc/GMT
Selected by peer and panel.
Selected "Top Doc 2011" by Northern Virginia Magazine: February Issue
Sun, 01/30/2011 - 18:50 — adminRepeat Prostate Biopsies - PROGENSA® PCA3 Assay Helps Determine, Approved By FDA
Sat, 02/18/2012 - 15:00 — adminOn Wednesday, the US Food and Drug Administration (FDA) approved Gen-Probe's PROGENSA® PCA3 (Prostate Cancer gene 3) assay, the first molecular test to help determine whether men with a previous negative biopsy need a repeat biopsy.
Prostate Cancer Survival Improves With Radiotherapy And Androgen Deprivation Therapy
Sat, 11/05/2011 - 14:22 — adminAn article published Online First in The Lancet reveals that men with locally advanced prostate cancer, which has not spread, who receive radiotherapy (RT) in combination with their androgen deprivation therapy (ADT) are more likely to have a greater overall chance of survival compared with those on ADT alone.
